Company of the Week: Kura Oncology
On 9 November 2026 Kura Oncology borrowed $50M from Oberland Capital under a facility of up to $275M and sold Oberland shares at $7.27. The loan comes with a royalty on American sales of KOMZIFTI that starts in October 2028 and stops at 20 percent of the principal drawn.